Alprostadil (prostaglandin E1)

DRUG2 trials

Sponsors

UCB Pharma

Conditions

Intermittent Claudication Fontaine Stage II PAODMacular DegenerationStage II Peripheral Arterial Occlusive Disease

Phase 3

Alprostadil in Maculopathy Study (AIMS)

TerminatedNCT00619229

UCB PharmaMacular Degeneration

Start: 2006-07-31End: 2010-02-28Updated: 2014-10-27

Prostaglandin E1 in Outpatients With Intermittent Claudication

CompletedNCT01263925

UCB PharmaIntermittent Claudication Fontaine Stage II PAOD, Stage II Peripheral Arterial Occlusive Disease

Start: 2001-04-30End: 2011-04-30Updated: 2014-10-27